General Surgery Residency Program alumnus
Chairman of Surgery, University of Rochester Medical Center
Professor of Surgery, University of Rochester
“I learned about a life of service and academic excellence."
Even as a teenager, Boston native David Linehan, MD, knew he wanted to be a
doctor. His early career choice was influenced by his mother, who founded
and ran a rehabilitation facility for men with alcohol and drug addictions,
and the Jesuit high school he attended. From both, says Dr. Linehan, “I
learned about a life of service and academic excellence.”
Service and academic excellence have always defined Dr. Linehan’s career. A
1997 graduate of the department’s General Surgery Residency Program, Dr.
Linehan was recently named Chair of Surgery at the University of Rochester
Medical Center, a position he assumes on October 1. He was formerly the
Neidorff Family and Robert C. Packman Professor of Surgery at Washington
University School of Medicine in St. Louis, where he worked since
completing a surgical oncology fellowship at Memorial Sloan-Kettering
Cancer Center in 1999.
Since 2007, Dr. Linehan served as Chief of the Division of Hepatobiliary,
Gastrointestinal Surgery at Washington University School of Medicine and
Barnes-Jewish Hospital, where he maintained a high-volume clinical practice
focusing largely on cancer patients. He was also Director of the HPB/GI
Fellowship Training Program, one of the most
competitive such fellowships in the nation.
Dr. Linehan devotes nearly half of his time to translational research aimed
at finding a novel,
effective treatment for pancreatic cancer, one of the deadliest
malignancies. For the past 15 years he has focused on understanding the
intricacies of the pancreatic tumor microenvironment.
This work led to his discovery that pancreatic tumors mobilize stromal
cells from the bone marrow and that these cells, which suppress the immune
response, play a key role in the growth and spread of tumors. “We
hypothesized that if we could block these cells, we could reverse the
immunosuppression and improve the effectiveness of chemotherapy,”
explains Dr. Linehan.
Using a drug called a CCR2 inhibitor, which prevents the mobilization of
these cells from the bone marrow, Dr. Linehan and his team demonstrated
efficacy in preclinical models. The drug is now being evaluated in patients
with locally advanced pancreatic cancer. “It’s pretty exciting that a
concept developed in our lab is now in [phase 2] clinical trials,” he says.
Last year, Dr. Linehan received a $1.25 million RO1 grant, “CCR2 Blockade
in Human Pancreatic Cancer,” from the National Institutes of Health to take
this research to the next level. And this year, he was named to a
multi-institutional Stand Up To Cancer (SU2C) Pancreas Cancer “Dream Team”
to further pursue this area of investigation.
Dr. Linehan’s commitment to all domains of academic surgery — patient care,
research — was inspired by his experiences as a surgical resident. A
graduate of Dartmouth College and the University of Massachusetts Medical
School, Dr. Linehan is grateful to have trained under Glenn Steele Jr., MD,
PhD. “Dr. Steele was a fantastic role model — a true triple threat: an
outstanding administrator, researcher, and surgeon,” says Dr. Linehan. “He
set a tone and standard that many of us benefited from.”
Dr. Linehan says he also benefited from the broad and diverse training and
research opportunities offered by the BIDMC surgical residency, which he
describes as the “best in Boston.” During his residency, Dr. Linehan spent
two years in a research fellowship in tumor immunotherapy at Brigham and
Women’s Hospital with Timothy Eberlein, MD.
Dr. Eberlein, who recruited Dr. Linehan to St. Louis, is now Chairman of
Surgery at Washington University School of Medicine. Despite his packed
schedule, which also includes serving in leadership roles in numerous
professional societies and as an editorial board member of
JAMA Surgery, Dr. Linehan, a married father of two teenaged sons, still
finds time to return to New England every year, where he enjoys visiting
family, downhill skiing, fishing, and spending time at his summer home on
the Maine coast. But even when he’s relaxing, Dr. Linehan’s goal — to find
a better treatment or even a cure for pancreatic cancer — is never far from